Article Text

Download PDFPDF

5PSQ-003 Development and applicability of the MedHipPro-Q: a questionnaire assessing medical doctors’ experience with medication management in the hip fracture patient pathway
  1. BT Henriksen1,
  2. RD Andersen2,
  3. M Krogseth3,
  4. L Mathiesen4,
  5. MN Davies1,
  6. Y Andersson5
  1. 1Tonsberg Hospital Pharmacy, Department of Pharmaceutical Services and Clinical Pharmacy, Tonsberg, Norway
  2. 2Telemark Hospital Trust, Department of Research, Skien, Norway
  3. 3Vestfold Hospital Trust, Old Age Psychiatry Research Network, Telemark Vestfold, Tonsberg, Norway
  4. 4University of Oslo, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Oslo, Norway
  5. 5Hospital Pharmacies Enterprise, South Eastern Norway, Department of Research, Oslo, Norway


Background and importance Hip fracture patients are characterised by polypharmacy and multiple care transitions within and between home, hospital, and rehabilitation institution/nursing home (ie, the patient pathway). Each care transition increases the risk of medication discrepancies. Thus, there is need to achieve a correct medication list, optimised for each patient, and ensure a seamless patient handover. Before implementing a clinical pharmacist intervention to address these issues, an evaluation of medical doctors’ perceptions of the current situation was needed. However, no appropriate questionnaire was identified.

Aim and objectives To develop a valid and feasible questionnaire to assess medical doctors’ experience with medication management of hip fracture patients in all care settings, and present an example of its applicability.

Material and methods The study took place in a region in South-Eastern Norway (approximate population: 250 000) from September 2017 to August 2018. The emerging questionnaire (MedHipPro-Q) was developed qualitatively through semi-structured interviews with stakeholders, cognitive interviews with future respondents, and a feasibility test. The novel MedHipPro-Q was thereafter distributed to hospital doctors.

Results Three questionnaire dimensions were identified: (1) Medication reconciliation and review, (2) Communication of key information and (3) Profession and setting. The MedHipPro-Q showed face and content validity through its representativeness of how stakeholders experienced medication management in all settings, and good feasibility. Almost half of the doctors in the emergency care unit responded (n = 9/20). They described medication lists missing at admission (n = 7/9), and using median 6–10 (range 3–20) min writing the medication part of the admission journal. In the orthopaedic department, 15/31 responded, and expressed that patients needed more medication reviews (n = 12/15), but wished for someone else to perform it (n = 13/15). A third of the doctors in the orthopaedic department (n = 5/15) always write the mandatory medication list at discharge.

Conclusion and relevance The MedHipPro-Q showed emerging validity and appeared feasible. It was able to identify problem areas that could be addressed by the planned clinical pharmacist intervention.

Conflict of interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.